Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IBIO - Bristol Myers Squibb's Newest Immunotherapy Approval And Other News: The Good Bad And Ugly Of Biopharma

IBIO - Bristol Myers Squibb's Newest Immunotherapy Approval And Other News: The Good Bad And Ugly Of Biopharma

iBio Inc.
  • Bristol Myers Squibb receives FDA approval for immunotherapy combo.
  • iBio inks deal with Safi Biosolutions for harnessing FastPharming System.
  • Otonomy reports completing patient recruitment for Otividex trial.

For further details see:

Bristol Myers Squibb's Newest Immunotherapy Approval, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: iBio Inc.
Stock Symbol: IBIO
Market: NYSE
Website: ibioinc.com
Menu
IBIO IBIO Quote IBIO Short IBIO News IBIO Articles IBIO Message Board
Get IBIO Alerts

News, Short Squeeze, Breakout and More Instantly...